Patients With Atypical Symptoms of Depression Respond Better to Lithium Augmentation Than Patients Without Atypical Symptoms
Acta Psychiatrica Scandinavica · 2026
DOI: 10.1111/acps.70127 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Acta Psychiatrica Scandinavica, 2026. Verfasst von Hannah Buchbauer und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Neuroscience, Campus Charité Mitte, Charité-Universitätsmedizin Berlin, Berlin, Germany. Hauptthemen laut MEDLINE: Antidepressive Agents, Lithium Compounds, Major Depressive Disorder. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Lundbeck GmbH, Mood Disorders Research Group.
Themen: Depression
Abstract (Originalsprache)
Introduction
Understanding the differences in treatment response between subtypes of major depressive disorder (MDD) may help to prevent lengthy trial‐and‐error processes by identifying effective treatment options. The aim of the study was to investigate the impact of atypical features of MDD (MDD‐A) on the response to lithium augmentation (LA).
Methods
In a multicenter prospective cohort study, response to LA was compared between patients with atypical symptoms of MDD (MDD‐A, n = 24) versus patients without atypical symptoms (MDD‐nA; n = 94) using a Cox regression analysis.
Results
A total of 62.5% of patients with MDD‐A and 36.2% of patients with MDD‐nA responded to LA. Analysis adjusted for age, sex, sufficient lithium serum concentration, and symptom severity at baseline showed a significantly higher probability of patients with atypical symptoms to respond to LA (HR 2.20, p = 0.02).
Conclusion
This is the first study investigating lithium‐response in patients with MDD‐A. The MDD‐A subtype may help to predict response to LA. Trial Registration: EudraCT number: 2008‐004182‐26; ClinicalTrials.gov identifier: DRKS00026205
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry and Neuroscience, Campus Charité Mitte, Charité-Universitätsmedizin Berlin, Berlin, Germany.
- Department of Psychiatry and Psychotherapy, Fliedner Klinik Berlin, Berlin, Germany.
- Department of Statistics, Informatics and Data Science, Jena University Hospital, Jena, Germany.
- Charité Center for Prevention, Health and Human Sciences, Research Unit Gender in Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany.
- Department of Psychiatry and Psychotherapy, Technical University of Dresden Medical School, Dresden, Germany.
- Faculty of Medicine and Psychology, Brandenburg Medical School Theodor Fontane, Neuruppin, Germany.
ORCID-Profile: Hannah Buchbauer, Mazda Adli, Peter Schlattmann, Maximilian Berger, Pichit Buspavanich
Förderung
- Lundbeck GmbH
- Mood Disorders Research Group
Zitieren
APA
Buchbauer, H., Adli, M., Schlattmann, P., Berger, M., Bschor, T., Stamm, T., Behr, J., Ricken, R., & Buspavanich, P. (2026). Patients With Atypical Symptoms of Depression Respond Better to Lithium Augmentation Than Patients Without Atypical Symptoms. Acta Psychiatrica Scandinavica. https://doi.org/10.1111/acps.70127
Vancouver
Buchbauer H, Adli M, Schlattmann P, Berger M, Bschor T, Stamm T, et al. Patients With Atypical Symptoms of Depression Respond Better to Lithium Augmentation Than Patients Without Atypical Symptoms. Acta Psychiatrica Scandinavica. 2026. doi:10.1111/acps.70127
BibTeX
@article{Buchbauer2026,
author = {Buchbauer, Hannah and Adli, Mazda and Schlattmann, Peter and Berger, Maximilian and Bschor, Tom and Stamm, Thomas and Behr, Joachim and Ricken, Roland and Buspavanich, Pichit},
title = {Patients With Atypical Symptoms of Depression Respond Better to Lithium Augmentation Than Patients Without Atypical Symptoms},
journal = {Acta Psychiatrica Scandinavica},
year = {2026},
doi = {10.1111/acps.70127}
}
EUVIMED